Development and application of biomarker methods in molecular environmental epidemiology for the detection of exposure to polycyclic aromatic hydrocarbons.

2.50
Hdl Handle:
http://hdl.handle.net/10146/283172
Title:
Development and application of biomarker methods in molecular environmental epidemiology for the detection of exposure to polycyclic aromatic hydrocarbons.
Authors:
Kovács, Katalin
Abstract:
My research aimed at the further development of the 32P-postlabelling method by which, whilst maintaining the adduct-labelling efficiency, the amount of the radioisotope per sample can be reduced, and thereby the sample processing capacity of the laboratory is increased. The regular and the modified 32P-postlabelling methods were used for comparative determinations of the levels of DNA adducts from various types of DNA samples, i.e. BPDE-DNA adduct standard, DNA samples from MCF-7 cell line treated with B[a]P, DNA samples from human non-tumorous peripheral lung tissue, human peripheral blood lymphocytes and human buffy coat samples. In the modified 32P-postlabelling method, the final reaction volume of the radio-labelling was reduced with an evaporation-to-dryness step to one-third of the volume that was used in the regular method. This facilitated the reduction of the amount of [γ-32P]ATP substrate from 50 μCi per sample – depending on the DNS isolation method – by 50% for the Qiagen-isolated samples (i.e., 25 μCi per sample) and by 80% for the DNA samples isolated with the classic phenol extraction procedure (i.e.,10 μCi) for both experimental and human samples. The newly-developed BPDE-DNA direct sandwich chemiluminescence immunoassay (BPDE-DNA SCIA) for the determination of PAH-DNA adducts has been published in 2012. Whereas in the earlier competitive immunoassays the signal to be measured is coupled to the DNA adducts, in the SCIA the chemiluminescent signal is coupled to the non-adducted nucleotides. In SCIA, the strong end-point signal derives from the many orders of magnitude difference between the number of the non-adducted and the adducted mononucleotides. The limit of detection of the method is ~ 1.5 adducts/109 nucleotides from 5 μg DNA sample. For the validation of BPDE-DNA SCIA, I performed comparative measurements between the immunoassay and the 32P-postlabelling method. The DNA samples were obtained from MCF 7 cells treated with B[a]P, from the liver of mice, which were treated in vivo with several doses of B[a]P, B[b]F, and DB[a,h]A, respectively, and from human maternal peripheral blood and newborn cord blood samples. For the B[a]P-DNA adduct levels measured by SCIA and 32P-postlabelling from the MCF 7 cells, the ratio between the adduct values was about 0.5. For the animal samples, the adduct levels were several times lower by the immunoassay than by the 32P-postlabelling method (the ratios were ≈1:5 for B[a]P, ≈ 1:30 for B[b]F and ≈ 1:5 for DB[a,h]A). All the same, there was a very strong, highly significant positive correlation between the DNA adduct measurements of the dose-response curves by SCIA and 32P-postlabelling for each PAH compound (r = 0.87-0.99). For the human samples, the ratio between the SCIA and 32P-postlabelling values was approximately 1:10, but there was not correlation between the data-pairs measured by the two methods. For the human samples, the lack of correlation between the two methods may be explained by the different efficiency of detection of different structural types of DNA adducts that are derived from complex human environmental exposure.
Citation:
Kovács K.: Development and application of biomarker methods in molecular environmental epidemiology for the detection of exposure to polycyclic aromatic hydrocarbons. PhD theses. University of Pécs Medical School, Pécs, 2012.
Publisher:
University of Pécs, 2012
Issue Date:
2012
URI:
http://hdl.handle.net/10146/283172
Type:
Thesis
Language:
en
Sponsors:
The following projects supported my PhD work: ECNIS (Environmental cancer risk, nutrition and individual susceptibility) EU FP6 R+D Network of Excellence (contract number: 513943); ECNIS2 (Towards ECNIS Centre for Research and Education on Cancer, Environment and Food) EU FP7 (contract number: 266198); NewGeneris (Newborns and Genotoxic exposure risks: Development and application of biomarkers of dietary exposure to genotoxic and immunotoxic chemicals and of biomarkers of early effects of using mother-child birth cohorts and biobanks) EU FP6 R+D Integrated project (contract number: 016320-2).
Appears in Collections:
Theses

Full metadata record

DC FieldValue Language
dc.contributor.authorKovács, Katalinen_GB
dc.date.accessioned2013-04-19T08:59:55Z-
dc.date.available2013-04-19T08:59:55Z-
dc.date.issued2012-
dc.identifier.citationKovács K.: Development and application of biomarker methods in molecular environmental epidemiology for the detection of exposure to polycyclic aromatic hydrocarbons. PhD theses. University of Pécs Medical School, Pécs, 2012.en_GB
dc.identifier.urihttp://hdl.handle.net/10146/283172-
dc.description.abstractMy research aimed at the further development of the 32P-postlabelling method by which, whilst maintaining the adduct-labelling efficiency, the amount of the radioisotope per sample can be reduced, and thereby the sample processing capacity of the laboratory is increased. The regular and the modified 32P-postlabelling methods were used for comparative determinations of the levels of DNA adducts from various types of DNA samples, i.e. BPDE-DNA adduct standard, DNA samples from MCF-7 cell line treated with B[a]P, DNA samples from human non-tumorous peripheral lung tissue, human peripheral blood lymphocytes and human buffy coat samples. In the modified 32P-postlabelling method, the final reaction volume of the radio-labelling was reduced with an evaporation-to-dryness step to one-third of the volume that was used in the regular method. This facilitated the reduction of the amount of [γ-32P]ATP substrate from 50 μCi per sample – depending on the DNS isolation method – by 50% for the Qiagen-isolated samples (i.e., 25 μCi per sample) and by 80% for the DNA samples isolated with the classic phenol extraction procedure (i.e.,10 μCi) for both experimental and human samples. The newly-developed BPDE-DNA direct sandwich chemiluminescence immunoassay (BPDE-DNA SCIA) for the determination of PAH-DNA adducts has been published in 2012. Whereas in the earlier competitive immunoassays the signal to be measured is coupled to the DNA adducts, in the SCIA the chemiluminescent signal is coupled to the non-adducted nucleotides. In SCIA, the strong end-point signal derives from the many orders of magnitude difference between the number of the non-adducted and the adducted mononucleotides. The limit of detection of the method is ~ 1.5 adducts/109 nucleotides from 5 μg DNA sample. For the validation of BPDE-DNA SCIA, I performed comparative measurements between the immunoassay and the 32P-postlabelling method. The DNA samples were obtained from MCF 7 cells treated with B[a]P, from the liver of mice, which were treated in vivo with several doses of B[a]P, B[b]F, and DB[a,h]A, respectively, and from human maternal peripheral blood and newborn cord blood samples. For the B[a]P-DNA adduct levels measured by SCIA and 32P-postlabelling from the MCF 7 cells, the ratio between the adduct values was about 0.5. For the animal samples, the adduct levels were several times lower by the immunoassay than by the 32P-postlabelling method (the ratios were ≈1:5 for B[a]P, ≈ 1:30 for B[b]F and ≈ 1:5 for DB[a,h]A). All the same, there was a very strong, highly significant positive correlation between the DNA adduct measurements of the dose-response curves by SCIA and 32P-postlabelling for each PAH compound (r = 0.87-0.99). For the human samples, the ratio between the SCIA and 32P-postlabelling values was approximately 1:10, but there was not correlation between the data-pairs measured by the two methods. For the human samples, the lack of correlation between the two methods may be explained by the different efficiency of detection of different structural types of DNA adducts that are derived from complex human environmental exposure.en_GB
dc.description.sponsorshipThe following projects supported my PhD work: ECNIS (Environmental cancer risk, nutrition and individual susceptibility) EU FP6 R+D Network of Excellence (contract number: 513943); ECNIS2 (Towards ECNIS Centre for Research and Education on Cancer, Environment and Food) EU FP7 (contract number: 266198); NewGeneris (Newborns and Genotoxic exposure risks: Development and application of biomarkers of dietary exposure to genotoxic and immunotoxic chemicals and of biomarkers of early effects of using mother-child birth cohorts and biobanks) EU FP6 R+D Integrated project (contract number: 016320-2).en_GB
dc.language.isoenen
dc.publisherUniversity of Pécs, 2012en_GB
dc.subjectPolycyclic aromatic hydrocarbonsen_GB
dc.subjectEnvironmental Exposureen_GB
dc.subjectDNA adductsen_GB
dc.subjectImmunoassaysen_GB
dc.subject32P-postlabellingen_GB
dc.subjectHumanen_GB
dc.subjectBiomarkersen_GB
dc.titleDevelopment and application of biomarker methods in molecular environmental epidemiology for the detection of exposure to polycyclic aromatic hydrocarbons.en
dc.typeThesisen
All Items in ECNIS-NIOM are protected by copyright, with all rights reserved, unless otherwise indicated.